Dr Daniel Breustedt and Filippo Gallegra from Novartis Pharma AG present their work on Breeding of Genetically Engineered Mouse Models – Challenges, Opportunities and Lessons Learned.

This presentation is part of the webinar on Avoidance of surplus – sustainability & efficiency in animal breeding, co-organized by ETH and the Swiss 3RCC on June 6th, 2024.